Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mallinckrodt public limited company (MNK)
NYSE MKT:MNK
Holding MNK?
Track your performance easily
MNK Stock Chart & Stats
Day’s Range$0.3 - $0.41
52-Week Range― - ―
Previous Close$0.4
Volume1.47K
Average Volume (3M)N/A
Market Cap
$1.70M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Nov 07, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mallinckrodt public limited company News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MNK FAQ
What was Mallinckrodt public limited company’s price range in the past 12 months?
Currently, no data Available
What is Mallinckrodt public limited company’s market cap?
Currently, no data Available
When is Mallinckrodt public limited company’s upcoming earnings report date?
Mallinckrodt public limited company’s upcoming earnings report date is Nov 07, 2023 which is 414 days ago.
How were Mallinckrodt public limited company’s earnings last quarter?
Mallinckrodt public limited company released its earnings results on Aug 09, 2023. The company reported -$56.652 earnings per share for the quarter, missing the consensus estimate of N/A by -$56.652.
Is Mallinckrodt public limited company overvalued?
According to Wall Street analysts Mallinckrodt public limited company’s price is currently Overvalued.
Does Mallinckrodt public limited company pay dividends?
Mallinckrodt public limited company does not currently pay dividends.
What is Mallinckrodt public limited company’s EPS estimate?
Mallinckrodt public limited company’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mallinckrodt public limited company have?
Currently, no data Available
What happened to Mallinckrodt public limited company’s price movement after its last earnings report?
Mallinckrodt public limited company reported an EPS of -$56.652 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -31.724%.
Which hedge fund is a major shareholder of Mallinckrodt public limited company?
Among the largest hedge funds holding Mallinckrodt public limited company’s share is Cyrus Capital Partners, L.P.. It holds Mallinckrodt public limited company’s shares valued at N/A.
---
Company Description
Mallinckrodt public limited company
Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which includes innovative specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of revenue from the United States.
---
Technical Analysis
---